Abstract
BackgroundLymphedema is a highly prevalent condition in women who have undergone treatment for breast cancer. Lymphedema negatively affects the quality of life. The objective of this study was to estimate the prevalence of lymphedema and associated factors in women treated for breast cancer in the municipality of Juiz de Fora.MethodsWe performed a cross-sectional study that evaluated 250 women who were being treated for breast cancer. Pre-screening of the sample by analysis of medical records was performed to select women who met the inclusion criteria as follows: women who had an operation more than 6 months ago; absence of active disease, locoregional or distant; the absence of functional change in the affected limb before surgery, which could lead to swelling of the limb; and simulating or masking symptoms of lymphedema, such as bursitis, tendonitis, and work-related musculoskeletal disorders. Women with bilateral breast cancer, absence of axillary intervention (partial or complete axillary dissection and/or SLN biopsy), active disease in the region, or lympho-venous alteration of the limb before surgery were excluded. Data were collected from the medical records of the selected cases, and they subsequently underwent an interview and a physical assessment.ResultsThe prevalence of lymphedema was 44.8%. There were medical records on the presence of this condition in 5.4% of cases. With regard to shoulder joint mobility, restrictions on abduction movements, internal and external rotation, and anterior shoulder adduction were significantly associated with lymphedema. Variables, including the presence of seroma, vascular changes, time elapsed after surgery, episodes of redness in the extremities, and cuticle removal from the hand with pliers were considered as major associated factors for lymphedema (p<0.05).ConclusionsThe prevalence of 44.8% for lymphedema found in this study is considered to be relevant because it is a morbidity that produces psychological, physical, and functional damage in patients with this condition. The planning of health programs and services appropriate for the immediate postoperative treatment of women with breast cancer, and increasing the awareness of health professionals regarding the early diagnosis of lymphedema, can help minimize the morbidity of this disease.
Highlights
Lymphedema is a highly prevalent condition in women who have undergone treatment for breast cancer
The time elapsed after surgery was significantly associated with the prevalence of lymphedema (p=0.028)
The current study found that the prevalence of patients with lymphedema after treatment for breast cancer was 44.8%
Summary
Lymphedema is a highly prevalent condition in women who have undergone treatment for breast cancer. There is still a high number of late diagnoses that contribute to the election of more aggressive therapy and subsequent traumatic surgery [2,7,8] This necessitates the improvement of therapeutic techniques to reduce the number of comorbidities presented. Even with the use of these approaches, studies show a high prevalence of postoperative morbidities, mainly regarding lymphedema [7,11,12,13] This condition arises from disruption of the lymphatic system in coping with the axillary approach for staging or control of the disease [8,14]. Improving the knowledge regarding risk factors associated with lymphedema in a given population will aid in the formulation of protocols for both its prevention and its treatment, enabling an improved quality of life for these women
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.